AUA Regional Meetings

Videos

“So yes, these transperineal biopsies are more painful right in the moment, but immediately following that, these patients are comfortable," says John Myrga, MD.

Study compares pain in transperineal and transrectal approach to prostate biopsy

Articles

John Myrga, MD, discusses recent findings on levels of pain, anxiety, and embarrassment for patients undergoing a prostate biopsy with a transperineal approach versus a transrectal approach.

Post-transperineal biopsy pain appears manageable for patients

“We have helped developed policies at the national level as far as parental leave for residents and fellows, helping to streamline a lot of that process with the American Board of Urology,” says Daniel Igel, MD.

Dr. Igel on role as SCS representative to the AUA residents and fellows committee

“I think the take home message of this study is that there's work to do, and that our efforts in diversity, equity, and inclusion extends broadly beyond simply ensuring that we have the workforce to treat our diverse population, or that urologists are thinking critically and responsibly about the needs of our patients,” says Kevin Koo, MD, MPH.

Dr. Koo on diversity, equity, and inclusion in urology drug trials

“One thing that from the very beginning we talked about is how can we push this forward? How can we think outside the box and take this to the next level to make an impact for our patients?” says Katie Murray, DO, MS.

Prostatic artery embolization as a collaboration between urology and interventional radiology

Two studies shared at the 2022 Annual Meeting of the South Central Section of the AUA highlighted onabotulinumtoxinA and sacral nerve stimulation as alternative treatment options for patients older than 70 years with overactive bladder.

Botox, sacral nerve stimulation highlighted as emerging OAB treatments for elderly patients

“The main finding of the study was that, like…other clinical trial studies in the past, we also found that there was an over representation of non-Hispanic White patients in these trials, and a dramatic under representation of people traditionally and historically underrepresented in clinical trials and in medicine,” says Kevin Koo, MD, MPH.



Study evaluates representation in urology drug trials

“A majority of the patients who were referred who had a catheter pre embolization are now catheter free,” says Kimberly Kocour, MD.

Dr. Kocour and Dr. Murray on embolization of the prostate

“This concept of adding additional therapy early on is ready for primetime,” says Michael S. Cookson, MD, MMHC.

Dr. Cookson on darolutamide data: “An exciting move forward”

“[With] some folks, if you don't accurately risk stratify them, you miss your chance to really build that trust as a provider,” says Neil Mistry, MD, MPH.